Immune mechanisms in malaria: new insights in vaccine development - Wikidata - wikimedia - TriplyDB

Immune mechanisms in malaria: new insights in vaccine development

Immune mechanisms in malaria: new insights in vaccine development

http://www.wikidata.org/entity/Q21032484

about

Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection "Asymptomatic" Malaria: A Chronic and Debilitating Infection That Should Be Treated The Use of Synthetic Carriers in Malaria Vaccine Design Profiling the host response to malaria vaccination and malaria challenge Does EBV alter the pathogenesis of malaria?Antimalarial drug discovery - approaches and progress towards new medicines.Co-evolution of human leukocyte antigen (HLA) class I ligands with killer-cell immunoglobulin-like receptors (KIR) in a genetically diverse population of sub-Saharan Africans Quantifying Transmission Investment in Malaria Parasites In vivo curative and protective potential of orally administered 5-aminolevulinic acid plus ferrous ion against malaria.Piecing together the puzzle of severe malaria.Production and preclinical evaluation of Plasmodium falciparum MSP-119 and MSP-311 chimeric protein, PfMSP-Fu24 Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease.Distinct patterns of diversity, population structure and evolution in the AMA1 genes of sympatric Plasmodium falciparum and Plasmodium vivax populations of Papua New Guinea from an area of similarly high transmission Association of antibody responses to the conserved Plasmodium falciparum merozoite surface protein 5 with protection against clinical malaria Strategies for designing and monitoring malaria vaccines targeting diverse antigens Antigen export during liver infection of the malaria parasite augments protective immunity Comparative analysis of IgG responses to Plasmodium falciparum MSP1p19 and PF13-DBL1α1 using ELISA and a magnetic bead-based duplex assay (MAGPIX®-Luminex) in a Senegalese meso-endemic community.A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine.Vaccines against malaria-still a long way to go.Memory B-cell and antibody responses induced by Plasmodium falciparum sporozoite immunization.A PfRH5-based vaccine is efficacious against heterologous strain blood-stage Plasmodium falciparum infection in aotus monkeys.Synchrony in malaria infections: how intensifying within-host competition can be adaptive Synergistic and antagonistic interactions between bednets and vaccines in the control of malaria.Laser mimicking mosquito bites for skin delivery of malaria sporozoite vaccines Malaria Vaccines: Moving Forward After Encouraging First Steps.Plasmodium berghei ANKA causes intestinal malaria associated with dysbiosis.Identification of Immunodominant Responses to the Plasmodium falciparum Antigens PfUIS3, PfLSA1 and PfLSAP2 in Multiple Strains of Mice Design, structure prediction and molecular dynamics simulation of a fusion construct containing malaria pre-erythrocytic vaccine candidate, PfCelTOS, and human interleukin 2 as adjuvant.Protective Effect of Chronic Schistosomiasis in Baboons Coinfected with Schistosoma mansoni and Plasmodium knowlesi.Circulating Th1-Cell-type Tfh Cells that Exhibit Impaired B Cell Help Are Preferentially Activated during Acute Malaria in Children.Experimental Immunization Based on Plasmodium Antigens Isolated by Antibody Affinity.Generation of Plasmodium falciparum parasite-inhibitory antibodies by immunization with recombinantly-expressed CyRPA Predicting optimal transmission investment in malaria parasites.A monoclonal antibody-based immunoassay to measure the antibody response against the repeat region of the circumsporozoite protein of Plasmodium falciparum.Transcriptomic profiling of microglia reveals signatures of cell activation and immune response, during experimental cerebral malaria.Contribution of the Ly49E natural killer receptor in the immune response to Plasmodium berghei infection and control of hepatic parasite development Protozoan Parasites and Type I IFNs.Characterization of Caveola-Vesicle Complexes (CVCs) Protein, PHIST/CVC-8195 in Plasmodium vivax.What Is Known about the Immune Response Induced by Plasmodium vivax Malaria Vaccine Candidates?Novel approaches in antimalarial drug discovery.

P2860

Q24628167-CB80D1D9-BA7F-4900-9F8B-151380175033 Q26771205-EB30C73B-AF77-4E67-8A29-4A1678E8CF61 Q26777053-74B8FD40-D3D1-4245-8E98-7CFEAD31A2A5 Q26800494-6D2585F1-2A22-4403-ACB8-0827AC7CCAF1 Q27022038-5D6223B5-CE7B-4FEB-87CA-8FE48F5F342B Q27693245-5E5CE5A3-5239-4362-B798-2337E440F318 Q28534758-C2EB12B3-E91D-4FFA-B14A-0B7856FABF6E Q28550263-17611669-BC77-4FBD-8EA8-929477818BFE Q30386961-432AB5A0-A719-4B17-BF75-B5FCF24A0DC5 Q33357028-7A4EA53D-0C98-4328-8889-7DA67B8EBB6F Q33743450-A7EC5F14-7021-4345-A479-550DCAE00F89 Q33821137-22787903-8179-4BF7-BDCC-0760BE09DB83 Q33859217-FFBB0C83-551F-420B-827E-DAE728B5B5BC Q33927906-29EB214C-CE83-4963-8E2A-269C27F77204 Q33959038-B8575C53-2498-44B2-8AE2-D392FF56B8B8 Q34026260-E781065F-EA15-42E4-A010-1A7795E2117C Q34460065-C1153575-D57F-463D-B313-294B73633DBA Q34487139-50B69EC5-3C62-4BD8-B705-3D93E146E89E Q34556687-2B15E394-1E65-4B3F-8AB7-FC0E981C68B9 Q34563555-5CA84283-14EF-480C-A50D-AF79486B3D16 Q34978590-1CA03D89-09AF-44B1-B838-2689822C27A5 Q35100308-60D670B8-F0CD-4B7D-8CB8-6D37592C4699 Q35189926-05CC7D68-F583-46E5-9856-50BC1F9C83AC Q35382689-2B5F9427-DF39-4526-BBF9-05D0876881DE Q35619891-4874801A-40D6-4FC2-AB85-B18293F066BA Q35822120-06E55C1D-3EC0-45C0-AC07-3A7218B99A4C Q35867348-9E69B07C-FA7C-43B6-83A4-58ED84295ED4 Q35916544-0392AC22-B64E-4498-A0BF-28CF2060C6F5 Q35925405-2D286F68-19B6-4DF3-9B35-450257F5E623 Q36167295-18F3D0D8-D824-471A-9405-EB68A5628830 Q36204459-FFA4ED45-67D7-480B-B4AB-D293DB738AF5 Q36687352-E67608A5-F702-4463-81CC-3A7745F2EEA2 Q37189977-0D360B4E-54F5-4B23-88AD-0B3553D74432 Q37402867-E0161435-F580-4825-970D-A8A5207AF61A Q37519276-B6303C99-EF53-4899-9A64-2EF850053B8A Q37534468-7EDBDBB8-4638-4D08-AD4A-0560D99BF9D4 Q37592659-E43BBE7C-E1EF-4EFF-8629-344E43B63866 Q37606588-12010FD9-397A-4D7D-A426-A5C76DE86430 Q37638131-94F3AA04-EE55-4EE2-BF92-984F2EF1F54D Q38148787-66C982B8-AF8D-47AC-91D1-4A16062C190A

P2860

Immune mechanisms in malaria: new insights in vaccine development

http://www.wikidata.org/entity/Q21032484

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Immune mechanisms in malaria: new insights in vaccine development

@ast

Immune mechanisms in malaria: new insights in vaccine development

@en

Immune mechanisms in malaria: new insights in vaccine development

@en-gb

Immune mechanisms in malaria: new insights in vaccine development

@nl

type

label

Immune mechanisms in malaria: new insights in vaccine development

@ast

Immune mechanisms in malaria: new insights in vaccine development

@en

Immune mechanisms in malaria: new insights in vaccine development

@en-gb

Immune mechanisms in malaria: new insights in vaccine development

@nl

prefLabel

Immune mechanisms in malaria: new insights in vaccine development

@ast

Immune mechanisms in malaria: new insights in vaccine development

@en

Immune mechanisms in malaria: new insights in vaccine development

@en-gb

Immune mechanisms in malaria: new insights in vaccine development

@nl

P1433

Q21032484-D0ABDA18-5B91-4279-ABAD-F7DE9948FDBF

P1476

Q21032484-BD24B411-78C0-43F7-9DDA-2A47F3B390B2

P2860

Q21032484-059EEF59-7A53-4D0C-A89F-E67FF5934204

Q21032484-0696997F-1B43-46C8-95CD-9B40F9CA1978

Q21032484-0830449B-3B4D-4F22-8328-AA160720A236

Q21032484-08774D2E-5D54-4FBF-959F-9F9161E2FD98

Q21032484-0BBAE8C9-2D61-43FD-B4CB-2F47DF1D23C1

Q21032484-0CCA6F36-7FE2-4BED-87B2-269BCD4650B7

Q21032484-0E6C127E-6899-48DE-9925-D0C2A21FE8FE

Q21032484-10578688-EA9F-4C11-9270-1DA783CA63D6

Q21032484-10F54339-2E1F-4A7A-B67B-8500D8D94B0F

Q21032484-12A08161-25FA-41A9-B1B4-5862120D6E40

P2888

Q21032484-75D4385C-924F-4365-B065-F89EAE0E67B4

P304

Q21032484-E9799B09-E38D-4BB4-9ACA-0A7564563CF8

P31

Q21032484-D45E3DB1-4147-4726-B180-E84B5CA7E974

P3181

Q21032484-D133C878-2B95-4135-98D3-9321D3972B61

P356

Q21032484-AB67AA0F-02A3-4793-BD38-4D79BC18306A

P4011

Q21032484-C1613909-AF48-4ED4-A38E-242494B2D61C

P407

Q21032484-41C83A2F-EC77-4AFF-903F-4EB5A6483AA9

P433

Q21032484-BCB37D78-DD23-4161-BD23-E24880C5CF9D

P478

Q21032484-10CC2E97-7F9D-4152-81D8-4E411263EC76

P50

Q21032484-3DC0A674-0590-4119-A812-6FBBEACCCEF4

Q21032484-EB508D33-78B7-4B2F-AC32-B16562718DBA

P577

Q21032484-877E58A0-8B17-45DC-BD63-47F7DDDA7C5F

P6179

Q21032484-71C48BFF-36DB-495E-9E3B-5273E5FED297

P698

Q21032484-51A1E181-6571-4413-8AB5-27FB460A4D4F

P921

Q21032484-9EF27482-0D12-4D8C-9DD7-B641EABEA0B5

Q21032484-E13323FC-40EC-47CC-A08E-B2DDE0446BD4

P3181

P356

P1433

Nature Medicine

P1476

Immune mechanisms in malaria: new insights in vaccine development

@en

P2860

Global malaria mortality between 1980 and 2010: a systematic analysis

Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum

Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria

A review of malaria vaccine clinical projects based on the WHO rainbow table

Acquired immunity to malaria

Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age

Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2

Profiling immunity to HIV vaccines with systems biology

IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection

P2888

P304

168-178

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2630673

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NM.3083

http://www.w3.org/2001/XMLSchema#string

P4011

02df4cc428f7130452479912c373142227c77273

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1040026844

http://www.w3.org/2001/XMLSchema#string

P698

23389617

http://www.w3.org/2001/XMLSchema#string

P921

vaccine development